Hyperlipidemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Consistent with the diagnosis of hyperlipidemia; ?45 = age < 75 years old; The ratio of male to female was about 1:1. ? good compliance, able to comply with the requirements of clinical trials; ? Subjects or their guardians have signed the informed consent; ? Patients completed a written informed consent form, basic situation questionnaire, and SF-36 Quality of Life questionnaire, and committed to cooperate with the study throughout the trial period; ? The blood, urine, stool, liver and kidney function tests were all in the normal range before treatment.
Exclusion criteria
Exclusion criteria: ? Secondary dyslipidemia or dyslipidemia caused by drugs; ? patients with serious cardiovascular and cerebrovascular diseases, liver and kidney function, endocrine system and other diseases; (3) patients with severe diarrhea or other diseases causing severe digestive dysfunction, digestive dysfunction, hepatic and renal insufficiency, and serious diseases of the gallbladder and pancreas; ? mental abnormality; ? regular intake of health care products, such as fish oil capsules 1-2 capsules/day; ? allergic to food (especially Perilla oil) or under other dietary treatment; ? patients receiving other medications that may have influenced the results of the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total cholesterol;Triglycerides;High density lipoprotein;Low density lipoprotein;short form 36 questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| Oil compliance; | — |
Countries
china
Contacts
Affiliated Hospital of Jiangnan University